EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factor XII–driven coagulation traps bacterial infections

Katrin F Nickel iD, Anne Jämsä iD, Sandra Konrath iD, Praveen Papareddy iD, Lynn M Butler iD, Evi X Stavrou iD, Maike Frye iD, Mathias Gelderblom iD, Bernhard Nieswandt iD, Sven Hammerschmidt iD, Heiko Herwald iD, Thomas Renné iD

Journal of Experimental Medicine · 2025

DOI: 10.1084/jem.20250049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Katrin F Nickel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Factor XII, Blood Coagulation, Bacterial Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Vetenskapsrådet, Case Western Reserve University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood coagulation is essential for stopping bleeding but also drives thromboembolic disorders. Factor XII (FXII)–triggered coagulation promotes thrombosis while being dispensable for hemostasis, making it a potential anticoagulant target. However, its physiological role remains unclear. Here, we demonstrate that FXII-driven coagulation enhances innate immunity by trapping pathogens and restricting bacterial infection in mice. Streptococcus pneumoniae infection was more severe in FXII-deficient (F12−/−) mice, with increased pulmonary bacterial burden, systemic spread, and mortality. Similarly, Staphylococcus aureus skin infections and systemic dissemination were exacerbated in F12−/− mice. Reconstitution with human FXII restored bacterial containment. Plasma kallikrein amplifies FXII activation, and its deficiency aggravated S. aureus skin infections, similarly to F12−/− mice. FXII deficiency impaired fibrin deposition in abscess walls, leading to leaky capsules and bacterial escape. Bacterial long-chain polyphosphate activated FXII, triggering fibrin formation. Deficiency in FXII substrate factor XI or FXII/factor XI co-deficiency similarly exacerbated S. aureus infection. The data reveal a protective role for FXII-driven coagulation in host defense, urging caution in developing therapeutic strategies targeting this pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor XIIBlood CoagulationBacterial InfectionsAnimalsMiceHumansStaphylococcus aureusMice, Inbred C57BLStaphylococcal InfectionsMice, KnockoutStreptococcus pneumoniaeImmunity, InnatePneumococcal InfectionsFibrin

Substanzen

Factor XIIFibrin

Autor:innen und Institutionen

  • Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Clinical Chemistry, Department of Molecular Medicine and Surgery, and Center of Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.
  • Clinical Chemistry, Medical Diagnostics, Karolinska University Hospital , Stockholm, Sweden.
  • Department of Laboratory Medicine, Biomedical Center (BMC), Lund University, Lund, Sweden.
  • Department of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway.
  • Science for Life Laboratory, Department of Protein Science, Royal Institute of Technology (KTH), Stockholm, Sweden.

ORCID-Profile: Katrin F Nickel, Anne Jämsä, Sandra Konrath, Praveen Papareddy, Lynn M Butler, Evi X Stavrou, Maike Frye, Mathias Gelderblom, Bernhard Nieswandt, Sven Hammerschmidt, Heiko Herwald, Thomas Renné

Förderung

  • NHLBI NIH HHS
  • Vetenskapsrådet
  • Case Western Reserve University
  • Oscar D. Ratnoff Endowed Professorship
  • German Research Foundation
  • Society of Thrombosis and Hemostasis Research
  • BLRD VA
  • NIH HHS

Zitieren

APA

Nickel, K. F., Jämsä, A., Konrath, S., Papareddy, P., Butler, L. M., Stavrou, E. X., Frye, M., Gelderblom, M., Nieswandt, B., Hammerschmidt, S., Herwald, H., & Renné, T. (2025). Factor XII–driven coagulation traps bacterial infections. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250049

Vancouver

Nickel KF, Jämsä A, Konrath S, Papareddy P, Butler LM, Stavrou EX, et al. Factor XII–driven coagulation traps bacterial infections. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20250049

BibTeX
@article{Nickel2025,
  author = {Nickel, Katrin F and Jämsä, Anne and Konrath, Sandra and Papareddy, Praveen and Butler, Lynn M and Stavrou, Evi X and Frye, Maike and Gelderblom, Mathias and Nieswandt, Bernhard and Hammerschmidt, Sven and Herwald, Heiko and Renné, Thomas},
  title = {Factor XII–driven coagulation traps bacterial infections},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1084/jem.20250049}
}
Kostenlos starten →